COVID19 seroconversion in an unrelated stem cell donor

Bone Marrow Transplant. 2021 Mar;56(3):723-725. doi: 10.1038/s41409-020-01066-z. Epub 2020 Sep 22.

Authors

Joseph E Maakaron¹, David McKenna Jr², Najla El-Jurdi², Mukta Arora², Claudio Brunstein², Steven Devine³, Sophia Yohe², Daniel Weisdorf²

Affiliations

¹ Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA. maaka001@umn.edu.
² Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA.
³ National Marrow Donor Program, Minneapolis, MN, USA.

No abstract available

Publication types

Letter

MeSH terms

COVID-19*
Hematopoietic Stem Cell Transplantation*
Humans
SARS-CoV-2
Seroconversion
Stem Cells
Unrelated Donors